127 related articles for article (PubMed ID: 15322182)
1. Vav-dependent and vav-independent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus.
Vigorito E; Bardi G; Glassford J; Lam EW; Clayton E; Turner M
J Immunol; 2004 Sep; 173(5):3209-14. PubMed ID: 15322182
[TBL] [Abstract][Full Text] [Related]
2. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors.
Weng WK; Jarvis L; LeBien TW
J Biol Chem; 1994 Dec; 269(51):32514-21. PubMed ID: 7528218
[TBL] [Abstract][Full Text] [Related]
3. BCR activation of PI3K is Vav-independent in murine B cells.
Vigorito E; Clayton E; Turner M
Biochem Soc Trans; 2004 Nov; 32(Pt 5):781-4. PubMed ID: 15494014
[TBL] [Abstract][Full Text] [Related]
4. CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.
Yazawa N; Fujimoto M; Sato S; Miyake K; Asano N; Nagai Y; Takeuchi O; Takeda K; Okochi H; Akira S; Tedder TF; Tamaki K
Blood; 2003 Aug; 102(4):1374-80. PubMed ID: 12714520
[TBL] [Abstract][Full Text] [Related]
5. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig.
Li X; Sandoval D; Freeberg L; Carter RH
J Immunol; 1997 Jun; 158(12):5649-57. PubMed ID: 9190913
[TBL] [Abstract][Full Text] [Related]
6. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav.
O'Rourke LM; Tooze R; Turner M; Sandoval DM; Carter RH; Tybulewicz VL; Fearon DT
Immunity; 1998 May; 8(5):635-45. PubMed ID: 9620684
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activation of PKD by the B cell antigen receptor and CD19 requires PI3K, Vav1 and PLCgamma.
Vigorito E; Kovesdi D; Turner M
Cell Signal; 2006 Sep; 18(9):1455-60. PubMed ID: 16380231
[TBL] [Abstract][Full Text] [Related]
8. Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation.
Ishiura N; Nakashima H; Watanabe R; Kuwano Y; Adachi T; Takahashi Y; Tsubata T; Okochi H; Tamaki K; Tedder TF; Fujimoto M
Eur J Immunol; 2010 Apr; 40(4):1192-204. PubMed ID: 20101619
[TBL] [Abstract][Full Text] [Related]
9. Cd19-dependent activation of Akt kinase in B-lymphocytes.
Otero DC; Omori SA; Rickert RC
J Biol Chem; 2001 Jan; 276(2):1474-8. PubMed ID: 11042164
[TBL] [Abstract][Full Text] [Related]
10. Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes.
Doody GM; Billadeau DD; Clayton E; Hutchings A; Berland R; McAdam S; Leibson PJ; Turner M
EMBO J; 2000 Nov; 19(22):6173-84. PubMed ID: 11080163
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation of B-cell adaptor for phosphoinositide 3-kinase is required for Akt activation in response to CD19 engagement.
Inabe K; Kurosaki T
Blood; 2002 Jan; 99(2):584-9. PubMed ID: 11781242
[TBL] [Abstract][Full Text] [Related]
12. Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade.
Li X; Carter RH
J Immunol; 1998 Dec; 161(11):5901-8. PubMed ID: 9834070
[TBL] [Abstract][Full Text] [Related]
13. CD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytes.
Dasu T; Sindhava V; Clarke SH; Bondada S
Mol Immunol; 2009 Aug; 46(13):2655-65. PubMed ID: 19541367
[TBL] [Abstract][Full Text] [Related]
14. The protein product of the proto-oncogene c-cbl forms a complex with phosphatidylinositol 3-kinase p85 and CD19 in anti-IgM-stimulated human B-lymphoma cells.
Beckwith M; Jorgensen G; Longo DL
Blood; 1996 Nov; 88(9):3502-7. PubMed ID: 8896416
[TBL] [Abstract][Full Text] [Related]
15. CD19 signaling pathways play a major role for murine AIDS induction and progression.
Knoetig SM; Torrey TA; Naghashfar Z; McCarty T; Morse HC
J Immunol; 2002 Nov; 169(10):5607-14. PubMed ID: 12421939
[TBL] [Abstract][Full Text] [Related]
16. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
Padmore L; An S; Gunby RH; Kelly K; Radda GK; Knox KA
Cell Immunol; 1997 May; 177(2):119-28. PubMed ID: 9178638
[TBL] [Abstract][Full Text] [Related]
17. The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigens.
Bachmann MF; Nitschke L; Krawczyk C; Tedford K; Ohashi PS; Fischer KD; Penninger JM
J Immunol; 1999 Jul; 163(1):137-42. PubMed ID: 10384109
[TBL] [Abstract][Full Text] [Related]
18. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
[TBL] [Abstract][Full Text] [Related]
19. Defective CD19-dependent signaling in B-1a and B-1b B lymphocyte subpopulations.
Sen G; Wu HJ; Bikah G; Venkataraman C; Robertson DA; Snow EC; Bondada S
Mol Immunol; 2002 Sep; 39(1-2):57-68. PubMed ID: 12213328
[TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines.
Brooks SR; Li X; Volanakis EJ; Carter RH
J Immunol; 2000 Mar; 164(6):3123-31. PubMed ID: 10706702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
